Skip to content
naulon

No retraction, correction or concern found when last checked on Oct 22, 2026.

A ribosome assembly stress response regulates transcription to maintain proteome homeostasis

Benjamin Albert, Isabelle C Kos-Braun, Anthony K Henras and 6 more

eLife · 2019 · CC BY

doi:10.1101/512665

Abstract

Ribosome biogenesis is a complex and energy-demanding process requiring tight coordination of ribosomal RNA (rRNA) and ribosomal protein (RP) production. Given the extremely high level of RP synthesis in rapidly growing cells, alteration of any step in the ribosome assembly process may impact growth by leading to proteotoxic stress. Although the transcription factor Hsf1 has emerged as a central regulator of proteostasis, how its activity is coordinated with ribosome biogenesis is unknown. Here, we show that arrest of ribosome biogenesis in the budding yeast Saccharomyces cerevisiae triggers rapid activation of a highly specific stress pathway that coordinately upregulates Hsf1 target genes and downregulates RP genes. Activation of Hsf1 target genes requires neo-synthesis of RPs, which accumulate in an insoluble fraction and presumably titrate a negative regulator of Hsf1, the Hsp70 chaperone. RP aggregation is also coincident with that of the RP gene activator Ifh1, a transcription factor that is rapidly released from RP gene promoters. Our data support a model in which the levels of newly synthetized RPs, imported into the nucleus but not yet assembled into ribosomes, work to continuously balance Hsf1 and Ifh1 activity, thus guarding against proteotoxic stress during ribosome assembly.

Full text

From PubMed Central, U.S. National Library of Medicine, as current on Oct 22, 2026. Paragraph numbers are ours, so an answer can point at one.

Introduction

Ribosome assembly is the most energy demanding process linked to cell growth and requires coordinated production of processed ribosomal RNAs (rRNAs), ribosomal proteins (RPs) and ribosome biogenesis (RiBi) factors. This massive biosynthetic program permits rapidly growing yeast cells to produce about 2000 ribosomes per minute, which is critical for sustaining high rates of growth (mass accumulation) and proliferation. At the same time, though, ribosome assembly poses a constant threat to cellular protein homeostasis and continued growth, since it requires the coordinated and large-scale assembly of four rRNAs with 79 different RPs, the latter of which are known to be highly prone to aggregation. Indeed, unassembled RPs in metazoans have long been known to activate p53, through titration of its negative regulator MDM2, and conserved p53-independent pathways that respond to perturbations in ribosome assembly are now beginning to emerge. Given the absence of p53 in yeasts, Saccharomyces cerevisiae is a promising model system in which to uncover ancestral processes that might monitor ribosome assembly to regulate growth and protein homeostasis in eukaryotes.

Heat shock factor 1 (Hsf1) is a central actor in Protein Quality Control (PQC) and protein homeostasis (proteostasis) in eukaryotes, in both stressed and unstressed cell, and in pathological situations. Notably, Hsf1 is a direct modulator of tumorigenesis and becomes essential, as it is in budding yeast, to support growth of malignant cells. Hsf1 prevents protein aggregation and proteome imbalance by driving the expression of a small regulon including genes encoding essential chaperones (Hsp70/Hsp90), nuclear/cytoplasmic aggregases, and proteasome components. Interestingly, studies in budding yeast reveal that the Ribosome Quality Control complex (RQC), conserved from yeast to human, increases Hsf1 activity under conditions of translation stress. However, many essential aspects of Hsf1 regulation remain to be elucidated, in particular whether its transcriptional activity is linked to ribosome biogenesis itself. Recently, a conserved PQC mechanism referred to as Excess Ribosomal Protein Quality Control (ERISQ) was described that specifically recognizes unassembled RPs in the nucleus and targets them for proteasome degradation, thus illuminating observations made 40 years ago showing that excess RPs are rapidly degraded. Sung and colleagues showed that the ubiquitin ligase Tom1 plays an important role in ESRIQ by preventing the accumulation of detergent-insoluble RPs. The potential role of Hsf1 in ERISQ has not yet been explored.

Given the tremendous investment of cellular resources involved in ribosome production and the fact that a decrease of ribosome abundance protects cells against proteotoxic stress, it might be expected that cells have evolved mechanisms to rapidly decrease RP gene transcription in the face of defects in ribosome assembly, in order to both save energy and reestablish cellular proteostasis. In S. cerevisiae, RP gene transcription is known to be tightly regulated according to growth conditions through the stress-sensitive transcription factor (TF) Ifh1. Thus, Ifh1 is rapidly released from RP promoters only minutes following inhibition of the conserved eukaryotic growth regulator Target Of Rapamycin Complex 1 (TORC1) kinase. Although it has been shown that Ifh1 promoter binding is coordinated with RNA polymerase I (RNAPI) activity upon prolonged TORC1 inhibition to help balance RP and rRNA production, how Ifh1 is removed from RP gene promoters to immediately downregulate their expression following stress remains a mystery. Furthermore, possible links between RP gene expression, ribosomal assembly and the protein homeostasis transcription program driven by Hsf1 remain important open questions.

In this study, we uncover a novel regulatory pathway, hereafter referred to as the Ribosomal Assembly Stress Response (RASTR), that allows rapid and simultaneous up-regulation of protein homeostasis genes and downregulation of RP genes following disruption of various steps in ribosome biogenesis (rRNA production, processing or RP assembly). We show that RASTR is highly specific to the RP and Hsf1 regulons, with little or no effect on a much larger group of genes implicated in the Environmental Stress Response (ESR). Importantly, RASTR requires neo-synthesis of RPs following stress and is linked to the accumulation of RP aggregates, which we propose lead to Hsf1 activation, through chaperone competition, and to the sequestration of Ifh1 in an insoluble nucleolar fraction. Notably, we show that protein synthesis inhabitation via cycloheximide treatment leads to a transcriptional response opposite to that of RASTR, supporting a model in which unstressed cells constantly monitor nuclear levels of unassembled RPs and use this information to balance expression of Hsf1 target genes with those encoding RPs. Finally, we demonstrate that RASTR is the initial transcriptional response to inactivation of TORC1 kinase, supporting a key role for this regulatory pathway in the activation of a protein homeostasis transcriptional program that allows cells to cope with the proteotoxic consequences of disruptions to ribosome biogenesis.

Topoisomerase depletion triggers a rapid repression of RP genes and activation of proteostasis genes

In an effort to better understand the role of the two major eukaryotic DNA topoisomerases in protein-coding gene transcription, we generated yeast strains in which Top1, Top2, or both of these enzymes are rapidly degraded by the auxin-induced degron (AID) method and confirmed by western blotting that significant depletion of either protein was obtained between 10 and 20 min following auxin addition to the medium, and that Top2 depletion, as expected, prevents cell growth (Figure 1—figure supplement 1A,B). We then performed ChIP-seq analysis of RNA polymerase II (RNAPII) in the Top1-AID, Top2-AID and Top1/2-AID strains at 20 and 60 min following auxin addition (Figure 1A–C, Supplementary file 1). As expected, the absence of Top2 had little or no effect on RNAPII distribution (Figure 1B). However, Top1 depletion triggered a rapid response at two specific groups of genes: upregulation of Hsf1 target genes and downregulation of RP genes (Figure 1A,D; Figure 1—figure supplement 1C,D). Remarkably, this response was transient, as both groups of genes returned to normal levels (i.e. before auxin addition) by 60 min. This re-equilibration was dependent upon Top2 since it failed to occur in the Top1/2-AID strain, where prolonged auxin treatment led to significant dysregulation of many other RNAPII-transcribed genes (Figure 1C).

Since upregulation of proteostasis-related genes and downregulation of RP genes are characteristic of many different stress responses, we decided to quantify the effect of Top1 depletion on transcription all gene groups that have been classified as part of the general ‘Environmental Stress Response’ (ESR; ), which include an additional group of stress-induced genes regulated by the Msn2/4 TFs and a large suite of genes involved in ribosome biogenesis (RiBi genes). This analysis shows clearly that Top1 depletion, as well as depletion of both Top1 and Top2 (at the early 20 min time point), triggers a highly specific stress response linked to RP genes and Hsf1 target genes (Figure 1A–C). Such a targeted response is unlikely to result from a global topological effect on RNAPII recruitment but would instead appear to be the consequence of the activation of a specific signaling pathway that is more restricted in nature than the ESR.

To explore the target(s) of this hypothetical signaling pathway at RP genes, we monitored by qPCR ChIP the promoter association of three TFs (Rap1, Fhl1 and Ifh1) that operate at the majority (>90%) of these 138 genes. Interestingly, we found that the activator Ifh1 is rapidly released from RP gene promoters after topoisomerases depletion (Figure 1E), whereas Rap1 and Fhl1, which bind directly to RP promoter DNA, are not affected (Figure 1—figure supplement 1E–F). To confirm that Hsf1 is indeed required for upregulation of genes following Top1 depletion, we used the anchor-away technique to rapidly remove Hsf1 from the nucleus (30 min treatment with rapamycin; ) before initiating Top1-AID degradation by auxin addition (Figure 1F). Efficient nuclear depletion of Hsf1 was confirmed by the inability of the Hsf1-FRB, Top1-AID strain to form colonies in the presence of rapamycin (Figure 1—figure supplement 1G). Note that the strain used in this and all other anchor-away experiments contains the TOR1-1 mutation and is thus resistant to the normal physiological consequences of rapamycin treatment, which inactivates the growth-promoting TORC1 kinase. This experiment revealed that Hsf1 nuclear depletion completely abolishes activation of stress genes following Top1 depletion without affecting down-regulation of RP genes (Figure 1G). Therefore, activation of stress-induced genes following Top1 depletion is completely Hsf1-dependent, whereas repression of RP genes is independent of Hsf1 or the induction of its target genes. We would also note that the stress pathway induced by Top1 depletion is unusually restricted in comparison to many other stress responses that are often grouped together as the Environmental Stress Response (ESR; ), since Msn2/4 target genes are not induced and RiBi genes are not downregulated (Figure 1A,G).

Top1 depletion arrests ribosome biogenesis and activates a ribosomal assembly stress response

Although it may seem surprising that depletion of topoisomerases can induce a Hsf1-dependent stress response, formation of distinct nuclear foci by the Btn2 aggregase and perinuclear accumulation of the proteasome subunit Pre6 following Top1/2 degradation (Figure 2—figure supplement 1A,B) both point to the induction of proteotoxic stress in the nucleus. Top1 was initially identified through a mutation (mak1) defective in large ribosomal subunit production and was later shown to be required for proper rRNA synthesis. Consistent with these findings, we observed a strong reduction of pre-rRNA synthesis as shown by decreased [3H]-adenine pulse-labeling of the RNAPI-transcribed 35S pre-rRNA, and two co-transcriptionally cleaved products, 27S and 20S pre-rRNAs, as early as 10 min after initiation of Top1 (or Top1 and Top2) depletion by addition of auxin to the medium (Figure 2—figure supplement 1C). This decreased rRNA synthesis is accompanied by an elongation defect, as shown by the accumulation of truncated pre-rRNAs that were initially described by the Tollervey laboratory (; Figure 2A). Further downstream, the rapid defect in rRNA production caused by inhibition of RNAPI elongation leads to unbalanced production of 40S and 60S ribosomal subunits, with a marked deficiency of the large (60S) subunit relative to the small (40S) subunit (Figure 2B). This would be expected to create a disequilibrium between RP and rRNA production, and more specifically an excess of unassembled RPs. Consistent with this, we detect accumulation of both and large and small subunit proteins (Rpl3 and Rps8, respectively) in trailing fractions of polysome gradients (Figure 2C). These observations strongly suggest that RPs fail to be incorporated normally into ribosomes immediately following topoisomerase degradation. In addition, this sedimentation profile may also reflect the presence of disassembling or incompletely assembled pre-60S particles. RPs are known to be prone to aggregation and recent reports show that newly synthetized, unassembled RPs accumulate in aggregates in response to ribosome assembly stress. Significantly, we also observed accumulation of RPs in an insoluble fraction following topoisomerase degradation (Figure 2D).

The observations described above led us to hypothesize that the transcriptional response to Top1 degradation is a consequence of defective ribosome assembly, perhaps driven by the proteotoxic stress caused by the accumulation of unassembled RPs. To challenge this idea, we measured the transcriptional response to three different perturbations to ribosome biogenesis: depletion of two essential ribosome assembly factors (Utp8 and Utp13) and treatment of cells with diazaborine. Utp8p is a member of the t-UTP subcomplex of 90S pre-ribosomes and its depletion inhibits rDNA transcription, leading to a reduction of the primary 35S pre-rRNA transcript and subsequent processing intermediates. In contrast, depletion of Utp13 (a member of the UTP-B subcomplex) interferes with downstream processing and synthesis of 40S subunits and causes decreased 18S rRNA levels without affecting the levels of the 25S or 5.8S rRNAs. Diazaborine, an inhibitor of the essential Drg1 AAA-ATPase, rapidly blocks mid-late steps of 60S subunit maturation. Remarkably, all these treatments triggered a similar transcriptional response to that which occurs following Top1 depletion, namely a specific downregulation of RP genes and upregulation of Hsf1 target genes (Figure 2E–G; Supplementary file 2), which we refer to as the ‘Ribosome Assembly STress Response’ (RASTR).

Hsf1 activity is stimulated by many different types of cellular stress, including stalled ribosomes. A pioneering study reported that a set of proteins termed the RQC binds to 60S ribosomal subunits containing stalled polypeptides and leads to their degradation. In the process, the RQC triggers a specific stress signal that leads to Hsf1 target gene activation. Thus, cells lacking a component of the RQC, the Tae2 protein, fail to activate Hsf1 following translational stress. To ask if RASTR might be related to the RQC, we induced Top1/2 degradation in tae2-Δ cells. We found that activation of two Hsf1 target genes (SSA1 and HSP42) and downregulation of two RP genes (RPL30 and RPL39) was unaffected by deletion of TAE2 (Figure 2—figure supplement 1D) and conclude that RQC does not play a role in RASTR. These results highlight that cells have developed distinct mechanisms to adapt the Hsf1 transcriptional program to defects in both ribosome activity and ribosome assembly.

Ifh1 sequestration in an insoluble nuclear fraction during RASTR is driven by RP accumulation

Although many studies would support the notion that Hsf1 activation during RASTR occurs through sequestration of its inhibitory partner Hsp70 by RP aggregates, it is less clear how ribosome assembly stress could trigger release of Ifh1 from RP gene promoters. We reported previously that the association of Ifh1 with RP gene promoters in growing cells is rapidly disrupted (within 5 min) following inhibition of the growth-promoting TORC1 kinase by addition of rapamycin to the medium. More recently, we found that stable release of Ifh1 from RP gene promoters (measured 20 min after rapamycin addition) requires its C-terminal domain together with a complex of proteins containing casein kinase 2 (CK2) and two RiBi factors, Utp22 and Rrp7, with which Ifh1 interacts to form the CURI complex. Thus, in ifh1-ΔC cells the truncated protein is rapidly released but later returns to RP gene promoters following TORC1 inhibition. This led us to propose two distinct mechanisms controlling the promoter release of Ifh1 following stress: one operating at a short timescale (<5 min) and the other on a long timescale (~20 min). Interestingly, ifh1-ΔC promoter release is stable following Top1 depletion, suggesting that an unknown mechanism regulates Ifh1 during RASTR (Figure 3A).

The fact that RP gene repression and Hsf1 target gene activation occur with identical kinetics following RASTR activation (Figure 3B), and that Ifh1 concentrates in nuclear foci rapidly after topoisomerase depletion (Figure 3C), suggests that Ifh1 could be sensitive to the accumulation of unassembled RPs in the nucleus, as is presumably the case for Hsf1. Several lines of evidence are consistent with this hypothesis. To begin with, in cells lacking Tom1, an E3 ligase required for degradation of unassembled RPs, but not in TOM1 cells, Ifh1 accumulates in prominent nuclear foci even in the absence of stress (Figure 3D). This suggests that Ifh1 aggregates in cells that are unable to efficiently degrade excess RPs, even under optimal growth conditions. Consistent with this, the published mass spectrometry data of insoluble fractions from cells either treated with the proteasome inhibitor bortezomib or lacking Tom1 clearly identified Ifh1, together with RPs, RiBi proteins and two Hsp70 proteins, Ssa1 and Ssa2, inhibitory partners of Hsf1 (Figure 3—figure supplement 1A). These data indicate that Ifh1 could be trapped in an insoluble cellular fraction in the absence of Tom1 and thus decrease the pool of Ifh1 able to bind with RP gene promoters. To test this possibility, we combined deletion of TOM1 with a mutant allele of IFH1 (ifh1-AA) that weakens its interaction with RP gene promoters. Remarkably, tom1-Δ is synthetically lethal with ifh1-AA (Figure 3E) supporting the notion that RP aggregation could directly impact on Ifh1 promoter binding. Lastly, to exclude the possibility that the genetic interaction between TOM1 and the mutated allele of IFH1 could be linked to the growth defect of this mutation, we examined another mutated allele of IFH1 (ifh1-6) that triggers a similar growth defect (Figure 3E). Importantly, we showed in a previous study that this ifh1-6 mutant protein remains bound at high levels to RP genes promoter even under stress conditions. Remarkably, tom1-Δ is not synthetically lethal with ifh1-6 (Figure 3E), supporting the notion that genetic interaction with ifh1-AA is directly linked to the ability of Ifh1 to bind RP gene promoters.

To assess directly whether Ifh1 is sequestered in aggregates during RASTR, we analyzed by mass spectrometry the insoluble fraction following topoisomerase depletion. As previously reported for tom1-Δ cells, the insoluble fraction is enriched in chaperones and RPs (Figure 3F,G). We also noted a strong increase in RiBi factors, primarily those implicated in biogenesis of the large ribosomal subunit (Figure 3G). Importantly, Ifh1 was never detected in an insoluble fraction in the absence of stress but was invariably detected in these fractions following topoisomerase depletion (Supplementary file 3). This rapid sequestration of Ifh1 may be sufficient to explain the observed downregulation of RP genes during RASTR.

Neo-synthetized RPs are required for RASTR activation

Given their fast turnover rate, nuclear accumulation in the absence of ribosome assembly and propensity to aggregate, unassembled RPs could be ideally positioned to rapidly signal ribosome biogenesis defects. To evaluate the importance of newly synthetized RPs in RASTR, we blocked their production by cytoplasmic anchoring of Ifh1 before topoisomerase depletion (Figure 4A). It is important to note that Ifh1 binding is highly specific to RP genes and that the transcriptional effect of its nuclear depletion is restricted to RP genes and a very small number of additional targets (Supplementary file 4). Although Ifh1 depletion by anchor-away may not be complete (the strain still grows on plates containing rapamycin, albeit slowly, even though Ifh1 is essential for growth; Figure 4—figure supplement 1A), it nonetheless leads to a significant and highly specific decrease in RP gene transcription as measured by RNAPII ChIP-seq (Figure 4B; Supplementary file 4). Interestingly, Ifh1 depletion also leads to aberrant rRNA processing (Figure 4C) as would expected in conditions where RP levels become limiting. Remarkably, we noted that 60 min of Ifh1 anchoring alone, in the absence of topoisomerase depletion, also caused a significant down-regulation of Hsf1 target genes (Figure 4D; Supplementary file 4) even though Ifh1 is absent from the promoters of these genes (Figure 4—figure supplement 1B), suggesting that the Hsf1 transcriptional program is continuously influenced by RP production. Consistent with this idea, we found that upregulation of Hsf1 target genes was either abolished or strongly reduced (Figure 4E,F,G; Supplementary file 4) when Top1 or Top1 and Top2 were degraded following nuclear depletion of Ifh1, indicating that RP production is required for Hsf1 target gene activation during RASTR.

Cells balance RP production and Hsf1 activity even in the absence of stress

As an alternative approach to test the requirement for de novo RP synthesis to initiate RASTR we used cycloheximide treatment, which blocks all translational elongations, thus leading to rapid depletion of the nuclear pools of RPs (Figure 5A;;;; ). As reported by others, we confirmed that cycloheximide alone also triggers a rapid arrest of rRNA processing (Figure 5B). Quite strikingly, we observed a transcriptional response to cycloheximide treatment exactly opposite to that induced by RASTR, namely Hsf1 target gene downregulation and RP gene upregulation (Figure 5C; Supplementary file 5). This finding suggests that even in unstressed cells RP production may contribute to a basal level of Hsf1 activation while at the same time limiting Ifh1 activity at RP gene promoters.

Significantly, treatment of cells undergoing Top1 or Top1/2 depletion with cycloheximide (auxin + CHX) completely abolished both RP gene repression and activation of Hsf1 target genes (Figure 5D,E; Supplementary file 5). Indeed, Hsf1 target gene activation under these conditions is lower than in untreated cells and not significantly different than that seen in cells treated with cycloheximide alone (Figure 5—figure supplement 1A). These findings clearly demonstrate that RASTR is dependent upon de novo protein synthesis. Importantly, it was recently reported that cycloheximide treatment efficiently prevents aggregation of newly synthesized RPs following proteasome inhibition. Perhaps as a direct consequence of this, we found that CHX treatment also leads to strong reduction of Ifh1-eGFP nuclear foci that are observed in cells lacking the ubiquitin ligase Tom1, which is specifically required for efficient degradation of unassembled RPs (;; Figure 5—figure supplement 1B). Furthermore, Ifh1 dis-aggregation following cycloheximide exposure is associated with increased Ifh1 binding at a RP gene promoter, which becomes significant in tom1-Δ cells (Figure 5—figure supplement 1C). Similarly, cycloheximide treatment also prevents the release of Ifh1 from RP gene promoters in response to the activation of RASTR by topoisomerase depletion (Figure 5—figure supplement 1D). Considered as a whole, these data suggest that both RP and Ifh1 subnuclear structures (aggregates) are dynamic, promoted by de novo RP production upon RASTR initiation, and capable of influencing Ifh1 promoter binding. Consistent with this view, we observed a large increase in cells that accumulate RP (Rpl25) or Ifh1 nuclear aggregates during RASTR that is abolished in the presence of cycloheximide (Figure 5F,G; Figure 5—figure supplement 1E, F).

Taken together with the strong reduction of Hsf1 target gene activation following Ifh1 cytoplasmic anchoring, both in the presence and absence of topoisomerase degradation, our observations on the effect of cycloheximide highlight the interwoven nature of RP and Hsf1 target gene regulons and support the notion that unassembled, aggregated RPs constitute the primary RASTR-induced signal capable of regulating both Ifh1 and Hsf1 activities, albeit in an opposite direction. More generally, these data indicate that newly synthetized RPs, in both stressed and unstressed cells, operate as a central hub in coordinating the expression of RP genes themselves with the Hsf1-dependent activation of chaperone and proteasome genes.

RASTR is the first transcriptional response to environmental stress

We next turned our attention to the potential involvement of RASTR during more general stress responses that might also rapidly affect ribosome assembly. In an initial set of experiments, we inactivated the conserved growth-promoting TORC1 kinase by treatment of cells with rapamycin, which is known to mimic a major part of the environmental stress response, including osmotic and redox stress, as well as carbon, nitrogen, phosphate or amino acid starvation. As reported previously, rapamycin triggers a rapid arrest of rRNA processing (Figure 6A) and a decrease of RP and RiBi gene expression (Figure 6B,C; Supplementary file 6). Interestingly, we noted that Hsf1 target genes are transiently up- and downregulated at 5 and 20 min, respectively, following rapamycin addition (Figure 6B,C; Supplementary file 6), suggesting that RASTR is activated at the early time point but shortly thereafter turned off. Consistent with this view, it has been reported that RP production ceases around 15 min after rapamycin treatment, which we suggest would turn off the signal for RASTR, thus explaining the downregulation of Hsf1 target genes observed at 20 min.

To explore this hypothesis further, we took advantage of our observation that cycloheximide treatment prevents RASTR activation by either Top1 or Top1/2 degradation (Figure 5) and treated cells with cycloheximide 5 min before rapamycin addition of either 5 or 20 min (Figure 6D, see schematics of experimental protocols below the respective panels). Remarkably, this specifically prevented RP gene repression and Hsf1 target gene activation at 5 min following rapamycin addition, whereas at the longer time point (20 min) RP genes and Hsf1 were regulated independently of cycloheximide (Figure 6D,E; Supplementary file 6). Consistent with the early block in RP gene downregulation being due to a failure to initiate RASTR immediately following rapamycin addition, we showed that cycloheximide pre-treatment prevents release of Ifh1 from RP gene promoters at 5 min, but not at 20 min following rapamycin treatment (Figure 6F).

The effects of rapamycin treatment described above are fully consistent with our previous report demonstrating that regulation of RP gene transcription following TORC1 inactivation by rapamycin operates through two distinct mechanisms at short and long timescales, with the latter dependent on RNAPI activity and the CURI complex. The short timescale mechanism described here, which is dependent upon continued protein synthesis and presumably mediated by RASTR, allows cells to rapidly arrest RP production and avoid or minimize proteotoxic stress induced by arrested ribosome assembly. The second mechanism permits the resumption of RP production only when rRNA synthesis also resumes. These two mechanisms could be particularly useful to rapidly adapt ribosome production to new growth conditions.

To explore the possible generality of rapid RASTR-mediated shut-down of RP gene transcription in response to stress, we measured the transcriptional response to heat shock, which is known to transiently downregulate both RP gene and rRNA transcription. As expected, we observed strong downregulation of RP genes and upregulation of Hsf1 target genes only 5 min following a shift in temperature to 40°C (Figure 7A–C, left panels) that was also accompanied by strong upregulation of Msn2 target genes and downregulation of RiBi genes (Figure 7A, left panel). The heat-shock transcriptional response is thus much broader than that to ribosome assembly stress, despite their common effects on RP and Hsf1 target gene expression. Remarkably, though, we found that cycloheximide pre-treatment prevents the strong and immediate repression of RP genes following heat shock (Figure 7A,B; right panels; Supplementary file 6), consistent again with the idea that this facet of the heat-shock response is identical to that which occurs during RASTR. Importantly though, Hsf1 target genes are still activated following heat shock in the presence of cycloheximide (Figure 7A,C; right panels), presumably because the unfolding of thermo-labile proteins induced by heat shock is alone sufficient to activate Hsf1 even in the absence of continuing RP synthesis. Nevertheless, the striking requirement for de novo protein synthesis for RP gene downregulation following heat shock strongly suggests that RASTR plays an integral role in this component of the heat-shock response and thus may constitute the earliest transcriptional response, at the level of RNAPII, to a wide variety of stress conditions.

Discussion

In this study, we demonstrate the existence of a regulatory mechanism, which we refer to as the ribosome assembly stress response, or RASTR, that allows yeast cells to specifically coordinate the activity of two TFs, Hsf1 and Ifh1, with the functional state of ribosome assembly. Our data and several previous reports suggest that rapid ribosome biogenesis is a potentially proteotoxic process, in large part due to accumulation of unassembled RPs, whose production needs to be carefully coordinated at the transcriptional level, at least in yeast, together with that of chaperones and proteasome components (Figure 8). In this perspective, RASTR may play an essential role in minimizing the proteostasis burden imposed by high ribosome production rates, particularly under fluctuating environmental conditions.

Our data indicate that disequilibrium at any step-in ribosome biogenesis (rRNA transcription, early or late rRNA processing or assembly) will lead to RASTR activation until the pool of unassembled RPs decreases. Consequently, proteasome inhibition, dNTP depletion, DNA damage, nutrient and thermal stress, all of which are known to alter rRNA transcription or processing, or ribosome assembly (reviewed in ), are likely to activate RASTR, as do the genetic perturbations at different step of ribosome assembly described here. Taken together with previous reports, our data thus point to a critical role for RASTR in the transcriptional networks regulating both growth and protein homeostasis.

It is important to note that RPs are among the most abundant ubiquitinylated proteins that accumulate in the nucleus of proteasome-deficient S. cerevisiae and human cells, suggesting that the synthesis of RPs and their assembly into ribosomes must be tightly coordinated with the cell’s proteostasis capacity. Consistent with this view, we show here that induction of ribosome assembly stress is correlated with the rapid accumulation of RPs in a detergent-insoluble fraction and that blocking de novo RP production, either by anchoring away Ifh1 or treating cells with cycloheximide, diminishes or abolishes a key transcriptional consequence of RASTR, namely upregulation of Hsf1 target genes. Our observations thus strongly suggest that RP aggregates are an important activating signal for RASTR. Nevertheless, we and others detect a large number of additional proteins that accumulate in an insoluble fraction upon ribosome assembly stress, including many RiBi proteins (e.g. numerous rRNA helicases and processing factors), the RP gene activator Ifh1, and chaperones. At present, we do not know the precise molecular nature of these aggregates, which presumably accumulate in the nucleolar space, or even whether they represent a common structure. In any event, our data suggest that RP- and Ifh1-containing aggregates are highly dynamic since the promoter release of Ifh1 and activation of Hsf1 following Top1 degradation are rapidly reversed by Top2 compensation (Figure 1) and Ifh1 aggregates that appear in tom1-Δ cells quickly diminish following cycloheximide treatment (Figure 5—figure supplement 1A). We imagine that this provides a strong selective advantage by allowing cells to rapidly recover from a transient disruption of ribosome biogenesis.

Accumulation of proteins in insoluble fractions or aggregates underlies numerous diseases, as well as aging. However, certain protein aggregates appear to be dynamic structures that contribute to cellular fitness by protecting the cell during stress. For example, stress granules and P-bodies, two of the most intensively studied insoluble macromolecular aggregates, have emerged as important cytoplasmic regulators of gene expression by controlling the processing, sequestering and/or degradation of specific RNA transcripts. Interestingly, it has recently been reported that nucleolar proteins can form sub-compartmental structures by promoting liquid-liquid phase separation. Although further work will be required to characterize the composition, assembly and function of these nucleolar membrane-less structures, they are attractive candidates for regulatory hubs that could act by sensing ribosome biogenesis stress and controlling adaptive responses. With respect to the present study, we imagine that liquid phase-separated structures in the nucleolus could be directly involved in sequestration of Ifh1 during RASTR, as well as the titration of Hsp70 that we propose leads to Hsf1 activation. A challenge for future studies will be to characterize the physical properties of these postulated structures and their relevance to the transcriptional outputs that we measure here.

We showed previously that in strains where RNAPI is constitutively active Ifh1 is released from RP gene promoters shortly after TORC1 inhibition by rapamycin treatment (~5 min) but returns only 15 min later. This promoter re-binding does not occur in wild-type cells due to the action of two RiBi proteins (Utp22 and Rrp7) that can sequester Ifh1 in the CURI (Casein Kinase 2/Utp22/Rrp7/Ifh1) complex allowing to re-align RP gene expression with RNAPI activity. These findings revealed that S. cerevisiae has developed temporally distinct mechanisms to regulate RP gene expression. One of the keys finding in the present study is to confirm the existence of a two-step process in RP gene regulation and to link the first step to control of the Hsf1 regulon. We propose that this short timescale mechanism results from a rapid rise in unassembled RPs that occurs immediately following TORC1 inhibition, or other stresses that disrupt ribosome assembly, such as depletion of Top1 or RiBi factors.

Following ribosome assembly stress, we imagine that the rapid induction of Hsf1 target genes, in combination with the arrest of RP gene transcription, contributes to the eventual clearing of proteotoxic unassembled RPs from the nucleus, thereby removing the signal that promotes RASTR and leads to Ifh1 promoter release and Hsf1 activation. Accordingly, RP production is abolished by 20 min following TORC1 inhibition, suggesting that RASTR becomes inoperant, thus explaining the downregulation of Hsf1 genes (Figure 6B) and the switch to a secondary regulatory mechanism, involving sequestration of Ifh1 in the CURI complex, to align RP expression with rRNA production. Consistent with this view, the short time scale mechanism of RP gene downregulation is abolished by attenuating proteotoxicity through translation inhibition (cycloheximide treatment) whereas the long time scale process is insensitive to translation arrest but can be prevented by expression of a constitutively active RNAPI. These two independent mechanisms adapt RP gene expression to both rRNA production and ribosome assembly, thus minimizing the accumulation of unassembled RPs.

As alluded to above, ribosome assembly stress in higher eukaryotes has been studied extensively in the context of ribosomopathies, diseases often associated with RP gene haplo-insufficiencies, RP gene point mutations or mutations in RiBi factors. One hypothesis put forward to explain these observations is that unassembled RPs trigger a feedback mechanism that decreases transcription of ribosome biogenesis genes by inhibiting c-Myc function and arrests cell growth through p53 activation. It has also been recently reported that the rRNA helicase DDX21 binds to and activates RP gene promoters in a manner that may be sensitive to the status of ribosome biogenesis. Taken together, these findings suggest that unassembled RPs could mediate an ancestral process to regulate ribosome biogenesis conserved from prokaryotes to eukaryotes. Transcriptome analysis immediately following ribosome assembly stress in mammalian cells will be required to understand the interplay between these different mechanisms and may also uncover novel pathways.

Our work also provides insights into the connection between ribosome assembly and Hsf1 that was first revealed in a report from the Churchman lab that appeared as our work was being prepared for publication. Hsf1 is a key sensor of proteotoxic stress in all eukaryotes that controls a common set of chaperones conserved from yeast to human. One protective function reported for Hsf1 is its ability to reduce protein aggregate formation leading to neurogenerative diseases. On the other hand, Hsf1 also exerts a pro-oncogenic function through its ability to promote proteostasis in rapidly growing tumor cells. Despite its central function, a holistic understanding of the regulatory mechanisms that govern Hsf1 activity still missing. Our work and that of demonstrates that Hsf1 activity is tightly linked to ribosome biogenesis in yeast, in a manner independent of the previously described RQC mechanism that contributes to the dissociation of aberrant nascent polypeptides from the ribosome. These two mechanisms highlight the central importance of ribosome assembly and activity in regulation of cellular protein homeostasis through Hsf1. Although it is currently unknown if RASTR is conserved in metazoans, we note that RPs are also subjected to a high turnover rate compared to other nuclear components in mammalian cells and that proteasome or ribosome assembly inhibition trigger a rapid accumulation of RPs in the nucleus, whereas arrest of translation has an opposite effect. Importantly, it was reported that cycloheximide treatment also abolishes Hsf1 activity in mammalian cell by an unknown mechanism. We propose that a dynamic balance between unassembled and assembled RPs could be sensed by Hsf1 to constantly adjust protein homeostasis transcription programs in eukaryotes with translational flux, proteolysis and the rate of ribosome assembly (Figure 8), since disruption or hyperactivation of any of these processes will rapidly change nuclear levels of free RPs. Given the growing body of evidence linking Hsf1 activity to numerous diseases associated with proteotoxic stress, but also rapid cell growth in cancer, it will be of great interest to challenge this model in the future.

ChIP-Seq

Cultures of 50 mL in YPAD were collected at OD6000.4–0.8 for each condition. The cells were crosslinked with 1% formaldehyde for 5 min at room temperature and quenched by adding 125 mM glycine for 5 min at room temperature. Cells were washed with ice-cold HBS and resuspended in 3.6 mL of ChIP lysis buffer (50 mM HEPES-Na pH 7.5, 140 mM NaCl, 1 mM EDTA, 1% NP-40, 0.1% sodium deoxycholate) supplemented with 1 mM PMSF and 1x protease inhibitor cocktail (Roche). Samples were aliquoted in Eppendorf tubes and frozen. After thawing, the cells were broken using Zirconia/Silica beads (BioSpec). The lysate was spun at 13,000 rpm for 30 min at 4°C and the pellet was resuspended in 300 μl ChIP lysis buffer + 1 mM PMSF and sonicated for 15 min (30 s ON - 60 s OFF) in a Bioruptor (Diagenode). The lysate was spun at 7000 rpm for 15 min at 4°C. Antibody (1 μg / 300 μL of lysate, Abcam ab5131) was added to the supernatant and incubated for 1 hr at 4°C. Magnetic beads were washed three times with PBS plus 0.5% BSA and added to the lysates (30 μL of beads/300 μL of lysate). The samples were incubated for 2 hr at 4°C. The beads were washed twice with (50 mM HEPES-Na pH 7.5, 140 mM NaCl, 1 mM EDTA, 0.03% SDS), once with AT2 buffer (50 mM HEPES-Na pH 7.5, 1 M NaCl, 1 mM EDTA), once with AT3 buffer (20 mM Tris-Cl pH 7.5, 250 mM LiCl, 1 mM EDTA, 0.5% NP-40, 0.5% sodium deoxycholate) and twice with TE. The chromatin was eluted from the beads by resuspension in TE + 1% SDS and incubation at 65°C for 10 min. The eluate was transferred to an Eppendorf tube and incubated overnight at 65°C to reverse the crosslinks. The DNA was purified using High Pure PCR Cleanup Micro Kit (Roche). DNA libraries were prepared using TruSeq ChIP Sample Preparation Kit (Illumina) according to manufacturer’s instructions. The libraries were sequenced using an Illumina HiSeq 2500 and the reads were mapped to the sacCer3 genome assembly using HTSStation (shift = 150 bp, extension = 50 bp; ). To compare depleted versus non-depleted cells, we divided the signal from the + auxin and/or rapamycin and/or cycloheximide samples by the signal from the – auxin and/or rapamycin and/or cycloheximide (vehicle) samples and log2 transformed this value. All data from publicly available databases were mapped using HTS Station (http://htsstation.epfl.ch; ).

Yeast strains, primer DNAs and cell growth

Strains used in this study are listed in Supplementary file 7. For ChIP-qPCR, the primer sequences used a listed in Supplementary file 8. Experiments were typically performed with log phase cells harvested between OD600 0.4 and 0.8. Anchor-away of FRB-tagged proteins was induced by the addition of rapamycin (1 mg/ml of 90% ethanol/10% Tween stock solution) to a final concentration of 1 μg/ml. Depletion of AID-tagged protein was induced by the addition of auxin (3-indoloacetic acid) at 500 μM final concentration. Arrest of translation was induced by the addition of cycloheximide to a final concentration of 25 μg/ml. Cells are treated with diazaborine to a final concentration of 50 ug/ml.

Fluorescence microscopy

Cells were grown overnight at 30°C in SC medium (0.67% nitrogen base without amino acids (BD), 2% dextrose supplemented with amino acids mixture (AA mixture; Bio101), adenine, and uracil). Cells were diluted and were harvested when OD600 reached 0.4. Cells were spread on slides coated with an SC medium patch containing 2% glucose. Stacked images were recorded (Intelligent Imaging Innovations) at a spinning disc confocal inverted microscope (Leica DMIRE2) using the 100x oil objective and an Evolve EMCCD Camera (Photometrics).

Insoluble fraction purification and mass spectrometry

Isolation of protein aggregates from yeast cells was performed as described previously with slight modifications. 50 OD600 units (50 ml) of exponentially growing cells were harvested, and cell pellets were frozen in liquid N2. The cell pellets were resuspended in 1 ml lysis buffer (20 mM Na-phosphate pH 6.8, 10 mM DTT, 1 mM EDTA, 0.1% Tween, 1 mM PMSF, protease inhibitor cocktail and 100 units/ml zymolyase) and incubated at 30° C for 30 min. Chilled samples were treated by tip sonication (20%, 10 s, 2x) and centrifuged for 20 min at 600 g at 4°C. Aggregated proteins were pelleted at 16,000 g for 20 min at 4°C. After removing supernatants, insoluble proteins were washed once with Wash I buffer (20 mM Na-phosphate pH 6.8, 500 mM NaCl, 5 mM EDTA, 2% NP-40, 1 mM PMSF, and protease inhibitor cocktail), and centrifuged at 16,000 g for 20 min at 4°C. Insoluble proteins were washed with Wash II buffer (20 mM Na-phosphate pH 6.8, ice-cold), pelleted and sonicated (2x for 10 s) in 40 μl of Wash II buffer. For analysis by SDS-PAGE (4–12% acrylamide) and subsequent western blotting, proteins were first boiled in Laemmli buffer. 1x of the total cell lysate and 25x of the insoluble pellet fraction were separated and analyzed by Coomassie Blue staining or immunoblotting. Proteins were identified by shotgun mass spectrometry analysis at the Functional Genomics Center Zurich (ETH, Zurich) following TCA precipitation (20%) and acetone washing, according to posted procedures. Database searches were performed by using the Mascot (SwissProt, all species; SwissProt, yeast) search program, using very stringent settings in Scaffold (1% protein FDR, a minimum of 2 peptides per protein, 0.1% peptide FDR).

Polysome gradients

Yeast cells growing exponentially were treated or not with auxin for 20 min. 50 µg/mL cycloheximide (Sigma) was added directly to the culture medium. Cells were collected by centrifugation, rinsed with buffer K [20 mM Tris-HCl pH 7.4, 50 mM KCl, 10 mM MgCl2] supplemented with 50 µg/mL cycloheximide and collected again by centrifugation. Dry pellets were resuspended with approximately one volume of ice-cold buffer K supplemented with 1 mM DTT, 1 × Complete EDTA-free protease inhibitor cocktail (Roche), 0.1 U/µL RNasin (Promega) and 50 µg/mL cycloheximide. About 250 µL of ice-cold glass beads (Sigma) were added to 500 µL aliquots of the resuspended cells and cells were broken by vigorous shaking, three times 2 min, separated by 2 min incubations on ice. Extracts were clarified through two successive centrifugations at 13,000 rpm and 4°C for 5 min and quantified by measuring absorbance at 260 nm. About 30 A260 units were loaded onto 10–50% sucrose gradients in buffer K, and then centrifuged for 150 min at 39,000 rpm and 4°C in an Optima L-100XP Ultracentrifuge (Beckman-Coulter) using a SW41Ti rotor without brake. Following centrifugation, 18 fractions of 500 µl each were collected from the top of the gradients with a Foxy Jr. apparatus (Teledyne ISCO). The absorbance at 254 nm was measured during collection with a UA-6 device (Teledyne ISCO).

Pulse labeling, RNA extraction and Northern hybridization

Metabolic labeling of pre-rRNAs was performed as previously described with the following modifications. Strains were grown in synthetic glucose medium lacking adenine to an OD600 of 0.8. Auxin (0.5 mM) was next added to the cultures and cells were labeled for 2 min with [2,8-3H]-adenine (NET06300 Perkin Elmer) at 0, 10, 20 and 30 min following the addition of auxin. Cell pellets were frozen in liquid nitrogen. RNA extractions and Northern hybridizations were performed as previously described. For high-molecular-weight RNA analysis, 2 μg of total RNA were glyoxal denatured and resolved on a 1.2% agarose gel. Note that Northern hybridization was performed on [2,8-3H]-adenine labeled RNA. The membrane was first exposed to reveal neo-synthetized transcripts, and subsequent Northern hybridization revealed rRNA transcript abundance.

Data availability

Read counts for all RNAPII ChIP-seq experiments (integrated counts over the complete open reading frame of all protein-coding genes) are given in Supplementary file 1–6. Primary processed sequence files will be made available at Gene Expression Omnibus (GEO accession number GSE125226).

References 71

  1. 1.

    Albert B, Knight B, Merwin J, Martin V, Ottoz D, Gloor Y, Bruzzone MJ, Rudner A, Shore D. A molecular titration system coordinates ribosomal protein gene transcription with ribosomal RNA synthesis. Molecular Cell. 2016;64:720-733.

    Not in our library10.1016/j.molcel.2016.10.003

  2. 2.

    Beltrame M, Tollervey D. Identification and functional analysis of two U3 binding sites on yeast pre-ribosomal RNA. The EMBO Journal. 1992;11:1531-1542.

    Not in our library10.1002/j.1460-2075.1992.tb05198.x

  3. 3.

    Berry J, Weber SC, Vaidya N, Haataja M, Brangwynne CP. RNA transcription modulates phase transition-driven nuclear body assembly. PNAS. 2015;112:E5237-E5245.

    Not in our library10.1073/pnas.1509317112

  4. 4.

    Brandman O, Stewart-Ornstein J, Wong D, Larson A, Williams CC, Li GW, Zhou S, King D, Shen PS, Weibezahn J, Dunn JG, Rouskin S, Inada T, Frost A, Weissman JS. A ribosome-bound quality control complex triggers degradation of nascent peptides and signals translation stress. Cell. 2012;151:1042-1054.

    Not in our library10.1016/j.cell.2012.10.044

  5. 5.

    Brill SJ, DiNardo S, Voelkel-Meiman K, Sternglanz R. Need for DNA topoisomerase activity as a swivel for DNA replication for transcription of ribosomal RNA. Nature. 1987;326:414-416.

    Not in our library10.1038/326414a0

  6. 6.

    Brill SJ, Sternglanz R. Transcription-dependent DNA supercoiling in yeast DNA topoisomerase mutants. Cell. 1988;54:403-411.

    Not in our library10.1016/0092-8674(88)90203-6

  7. 7.

    Calo E, Flynn RA, Martin L, Spitale RC, Chang HY, Wysocka J. RNA helicase DDX21 coordinates transcription and ribosomal RNA processing. Nature. 2015;518:249-253.

    Not in our library10.1038/nature13923

  8. 8.

    Cherkasov V, Hofmann S, Druffel-Augustin S, Mogk A, Tyedmers J, Stoecklin G, Bukau B. Coordination of translational control and protein homeostasis during severe heat stress. Current Biology. 2013;23:2452-2462.

    Not in our library10.1016/j.cub.2013.09.058

  9. 9.

    Conconi A, Paquette M, Fahy D, Bespalov VA, Smerdon MJ. Repair-independent chromatin assembly onto active ribosomal genes in yeast after UV irradiation. Molecular and Cellular Biology. 2005;25:9773-9783.

    Not in our library10.1128/mcb.25.22.9773-9783.2005

  10. 10.

    Dai MS, Arnold H, Sun XX, Sears R, Lu H. Inhibition of c-Myc activity by ribosomal protein L11. The EMBO Journal. 2007;26:3332-3345.

    Not in our library10.1038/sj.emboj.7601776

  11. 11.
  12. 12.

    David FP, Delafontaine J, Carat S, Ross FJ, Lefebvre G, Jarosz Y, Sinclair L, Noordermeer D, Rougemont J, Leleu M. HTSstation: a web application and open-access libraries for high-throughput sequencing data analysis. PLOS ONE. 2014;9:e85879.

    Not in our library10.1371/journal.pone.0085879

  13. 13.

    Decker CJ, Parker R. P-bodies and stress granules: possible roles in the control of translation and mRNA degradation. Cold Spring Harbor Perspectives in Biology. 2012;4:a012286.

    Not in our library10.1101/cshperspect.a012286

  14. 14.

    Douglas PM, Treusch S, Ren HY, Halfmann R, Duennwald ML, Lindquist S, Cyr DM. Chaperone-dependent amyloid assembly protects cells from prion toxicity. PNAS. 2008;105:7206-7211.

    Not in our library10.1073/pnas.0802593105

  15. 15.

    El Hage A, French SL, Beyer AL, Tollervey D. Loss of topoisomerase I leads to R-loop-mediated transcriptional blocks during ribosomal RNA synthesis. Genes & Development. 2010;24:1546-1558.

    Not in our library10.1101/gad.573310

  16. 16.

    Feric M, Vaidya N, Harmon TS, Mitrea DM, Zhu L, Richardson TM, Kriwacki RW, Pappu RV, Brangwynne CP. Coexisting liquid phases underlie nucleolar subcompartments. Cell. 2016;165:1686-1697.

    Not in our library10.1016/j.cell.2016.04.047

  17. 17.

    French SL, Sikes ML, Hontz RD, Osheim YN, Lambert TE, El Hage A, Smith MM, Tollervey D, Smith JS, Beyer AL. Distinguishing the roles of topoisomerases I and II in relief of transcription-induced torsional stress in yeast rRNA genes. Molecular and Cellular Biology. 2011;31:482-494.

    Not in our library10.1128/mcb.00589-10

  18. 18.

    Gallagher JE, Dunbar DA, Granneman S, Mitchell BM, Osheim Y, Beyer AL, Baserga SJ. RNA polymerase I transcription and pre-rRNA processing are linked by specific SSU processome components. Genes & Development. 2004;18:2506-2517.

    Not in our library10.1101/gad.1226604

  19. 19.
  20. 20.

    Gómez-Herreros F, Rodríguez-Galán O, Morillo-Huesca M, Maya D, Arista-Romero M, de la Cruz J, Chávez S, Muñoz-Centeno MC. Balanced production of ribosome components is required for proper G1/S transition in saccharomyces cerevisiae. The Journal of Biological Chemistry. 2013;288:31689-31700.

    Not in our library10.1074/jbc.m113.500488

  21. 21.

    Gorenstein C, Warner JR. Synthesis and turnover of ribosomal proteins in the absence of 60S subunit assembly in saccharomyces cerevisiae. MGG Molecular & General Genetics. 1977;157:327-332.

    Not in our library10.1007/bf00268670

  22. 22.

    Grousl T, Ungelenk S, Miller S, Ho CT, Khokhrina M, Mayer MP, Bukau B, Mogk A. A prion-like domain in Hsp42 drives chaperone-facilitated aggregation of misfolded proteins. The Journal of Cell Biology. 2018;217:1269-1285.

    Not in our library10.1083/jcb.201708116

  23. 23.

    Guerra-Moreno A, Isasa M, Bhanu MK, Waterman DP, Eapen VV, Gygi SP, Hanna J. Proteomic analysis identifies ribosome reduction as an effective proteotoxic stress response. Journal of Biological Chemistry. 2015;290:29695-29706.

    Not in our library10.1074/jbc.m115.684969

  24. 24.

    Haruki H, Nishikawa J, Laemmli UK. The anchor-away technique: rapid, conditional establishment of yeast mutant phenotypes. Molecular Cell. 2008;31:925-932.

    Not in our library10.1016/j.molcel.2008.07.020

  25. 25.

    Heitman J, Movva NR, Hall MN. Targets for cell cycle arrest by the immunosuppressant rapamycin in yeast. Science. 1991;253:905-909.

    Not in our library10.1126/science.1715094

  26. 26.

    James A, Wang Y, Raje H, Rosby R, DiMario P. Nucleolar stress with and without p53. Nucleus. 2014;5:402-426.

    Not in our library10.4161/nucl.32235

  27. 27.

    Kaganovich D, Kopito R, Frydman J. Misfolded proteins partition between two distinct quality control compartments. Nature. 2008;454:1088-1095.

    Not in our library10.1038/nature07195

  28. 28.

    Knight B, Kubik S, Ghosh B, Bruzzone MJ, Geertz M, Martin V, Dénervaud N, Jacquet P, Ozkan B, Rougemont J, Maerkl SJ, Naef F, Shore D. Two distinct promoter architectures centered on dynamic nucleosomes control ribosomal protein gene transcription. Genes & Development. 2014;28:1695-1709.

    Not in our library10.1101/gad.244434.114

  29. 29.

    Koplin A, Preissler S, Ilina Y, Koch M, Scior A, Erhardt M, Deuerling E. A dual function for chaperones SSB-RAC and the NAC nascent polypeptide-associated complex on ribosomes. The Journal of Cell Biology. 2010;189:57-68.

    Not in our library10.1083/jcb.200910074

  30. 30.

    Kos-Braun IC, Jung I, Koš M. Tor1 and CK2 kinases control a switch between alternative ribosome biogenesis pathways in a growth-dependent manner. PLOS Biology. 2017;15:e2000245.

    Not in our library10.1371/journal.pbio.2000245

  31. 31.
  32. 32.

    Laferté A, Favry E, Sentenac A, Riva M, Carles C, Chédin S. The transcriptional activity of RNA polymerase I is a key determinant for the level of all ribosome components. Genes & Development. 2006;20:2030-2040.

    Not in our library10.1101/gad.386106

  33. 33.
  34. 34.

    Li J, Labbadia J, Morimoto RI. Rethinking HSF1 in stress, development, and organismal health. Trends in Cell Biology. 2017;27:895-905.

    Not in our library10.1016/j.tcb.2017.08.002

  35. 35.

    Liu Y, Liang S, Tartakoff AM. Heat shock disassembles the nucleolus and inhibits nuclear protein import and poly(A)+ RNA export. The EMBO Journal. 1996;15:6750-6757.

    Not in our library10.1002/j.1460-2075.1996.tb01064.x

  36. 36.

    Liu Y, Deisenroth C, Zhang Y. RP-MDM2-p53 pathway: linking ribosomal biogenesis and tumor surveillance. Trends in Cancer. 2016;2:191-204.

    Not in our library10.1016/j.trecan.2016.03.002

  37. 37.

    Loewith R, Hall MN. Target of rapamycin (TOR) in nutrient signaling and growth control. Genetics. 2011;189:1177-1201.

    Not in our library10.1534/genetics.111.133363

  38. 38.

    Loibl M, Klein I, Prattes M, Schmidt C, Kappel L, Zisser G, Gungl A, Krieger E, Pertschy B, Bergler H. The drug diazaborine blocks ribosome biogenesis by inhibiting the AAA-ATPase Drg1. Journal of Biological Chemistry. 2014;289:3913-3922.

    Not in our library10.1074/jbc.m113.536110

  39. 39.

    Mahat DB, Salamanca HH, Duarte FM, Danko CG, Lis JT. Mammalian heat shock response and mechanisms underlying its Genome-wide transcriptional regulation. Molecular Cell. 2016;62:63-78.

    Not in our library10.1016/j.molcel.2016.02.025

  40. 40.

    Mahboubi H, Stochaj U. Cytoplasmic stress granules: dynamic modulators of cell signaling and disease. Biochimica Et Biophysica Acta (BBA) - Molecular Basis of Disease. 2017;1863:884-895.

    Not in our library10.1016/j.bbadis.2016.12.022

All 71 references

Cited by papers we hold 2

Reads

Read by people on this page

None yet.

Checked or read by AI through naulon

None yet.

A person counts once a day per paper. We keep no cookie and no address: a reader is a hash that changes every day. Any month under five reads shows no number.

Are you an author?

Is this your paper?

Claim it to add your note and be paid when agents cite it. Free.